-
PROVIDERS
REGISTER NOW
AI in oncology: Fundamentals to full integration into your practice
Monday, September 15th
10:00am PT, 12:00pm CT, 1:00pm ET -
LIFE SCIENCES
READ NOW
Q&A: Harnessing generative AI to refine clinical research & drug development
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
11/20/2024
University of Washington
Researchers at Tempus partnered with the University of Washington to study the genomic alteration (GA) landscape of pure urothelial (UC) and histologic subtypes of bladder cancer.
This analysis promises to yield insight into variant histology bladder cancers to better understand their lack of clinical response, and potentially identify modes of therapeutic intervention.
This study was presented at the ASCO GU Cancers Symposium in 2024.
-
08/29/2025Precision Medicine 2.0: The operating system for oncology R&D
This white paper addresses the persistent challenges in oncology R&D, demonstrating how precision medicine has evolved into a new paradigm built on systems-level understanding and AI-driven insights. Download for a comprehensive overview of Precision Medicine 2.0, its core scientific pillars, enabling technologies, and how R&D organizations can leverage this integrated approach to optimize their cancer research.
Read more -
08/15/2025Tempus’ data solutions for commercialization
Learn how our multimodal real-world data can help quantify new market opportunities, build your value story, and inform your market access strategy.
Read more -
08/15/2025Tempus’ data solutions for clinical development
Learn how our multimodal real-world data can help you optimize trial design, mitigate risk, and inform your companion diagnostic strategy.
Read more